129 related articles for article (PubMed ID: 30983297)
21. A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers - DeNaCaPST programme.
Demoor-Goldschmidt C; Drui D; Doutriaux I; Michel G; Auquier P; Dumas A; Berger C; Bernier V; Bohrer S; Bondiau PY; Filhon B; Fresneau B; Freycon C; Stefan D; Helfre S; Jackson A; Kerr C; Laprie A; Leseur J; Mahé MA; Oudot C; Pluchard C; Proust S; Sudour-Bonnange H; Vigneron C; Lassau N; Schlumberger M; Conter CF; de Vathaire F
BMC Cancer; 2017 May; 17(1):326. PubMed ID: 28499444
[TBL] [Abstract][Full Text] [Related]
22. Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching.
Leuraud K; Jezewski-Serra D; Viguier J; Salines E
Cancer Epidemiol; 2013 Dec; 37(6):959-67. PubMed ID: 24035240
[TBL] [Abstract][Full Text] [Related]
23. Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.
Constantinou P; Dray-Spira R; Menvielle G
BMC Cancer; 2016 Mar; 16():255. PubMed ID: 27029643
[TBL] [Abstract][Full Text] [Related]
24. [Ethics of organized cancer screening in France].
Moutel G; Darquy S; Jullian O; Duchange N
Sante Publique; 2019; S2(HS2):67-74. PubMed ID: 32372582
[TBL] [Abstract][Full Text] [Related]
25. [Implementation of National Cervical Cancer Screening Program in France].
Woronoff AS; Molinié F; Trétarre B
Bull Cancer; 2019 Mar; 106(3):253-261. PubMed ID: 30635113
[TBL] [Abstract][Full Text] [Related]
26. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
27. [Organized breast cancer screening].
Rouëssé J; Sancho-Garnier H;
Bull Acad Natl Med; 2014 Feb; 198(2):369-86. PubMed ID: 26263710
[TBL] [Abstract][Full Text] [Related]
28. [The diffusion of screening programmes in Italy, year 2010].
Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
Epidemiol Prev; 2012; 36(6 Suppl 1):3-7. PubMed ID: 23293267
[TBL] [Abstract][Full Text] [Related]
29. Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
Ruan Y; Heer E; Brenner DR
Cancer; 2024 Jul; 130(13):2398. PubMed ID: 38642366
[No Abstract] [Full Text] [Related]
30. Effect of financial incentives on breast, cervical and colorectal cancer screening delivery rates: Results from a systematic literature review.
Mauro M; Rotundo G; Giancotti M
Health Policy; 2019 Dec; 123(12):1210-1220. PubMed ID: 31587819
[TBL] [Abstract][Full Text] [Related]
31. Cancer screening status in Korea, 2011: results from the Korean National Cancer Screening Survey.
Park B; Choi KS; Lee YY; Jun JK; Seo HG
Asian Pac J Cancer Prev; 2012; 13(4):1187-91. PubMed ID: 22799303
[TBL] [Abstract][Full Text] [Related]
32. Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer.
Tran TXM; Kim S; Cha C; Park B
Cancer Res Treat; 2024 Apr; 56(2):522-530. PubMed ID: 37905311
[TBL] [Abstract][Full Text] [Related]
33. [Role of general practitioners in cancer screening: A survey in the French armed forces].
Bellier T; Vallard A; Espenel S; Langrand-Escure J; Ben Mrad M; Védrine L; Magné N; Chargari C
Bull Cancer; 2015 Dec; 102(12):993-1001. PubMed ID: 26628076
[TBL] [Abstract][Full Text] [Related]
34. [Cancer screening in France: 10 years of analysis of behaviours by the EDIFICE surveys].
Eisinger F; Pivot X; Greillier L; Couraud S; Cortot AB; Touboul C; Lhomel C; Blay JY; Morère JF; Viguier J
Bull Cancer; 2017 Mar; 104(3):258-266. PubMed ID: 28108012
[TBL] [Abstract][Full Text] [Related]
35. Participants' characteristics in a French colorectal cancer mass screening campaign.
Herbert C; Launoy G; Thezee Y; Maurel J; Richir B; Reaud JM; Ollivier V; Pegulu L; Valla A; Gignoux M
Prev Med; 1995 Sep; 24(5):498-502. PubMed ID: 8524725
[TBL] [Abstract][Full Text] [Related]
36. Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty one European countries using the Barriers to Effective Screening Tool (BEST).
Priaulx J; de Koning HJ; de Kok IMCM; Széles G; McKee M
Health Policy; 2018 Nov; 122(11):1190-1197. PubMed ID: 30177278
[TBL] [Abstract][Full Text] [Related]
37. Cancer screening - pros, cons, choice, and the patient.
Trevena L
Aust Fam Physician; 2009 Apr; 38(4):188-92. PubMed ID: 19350066
[TBL] [Abstract][Full Text] [Related]
38. [National web portals as an official communication platform of cancer screening programmes].
Gregor J; Dušek L; Májek O; Snajdrová L
Klin Onkol; 2014; 27 Suppl 2():124-7. PubMed ID: 25494897
[TBL] [Abstract][Full Text] [Related]
39. Participation in breast cancer screening and its influence on other cancer screening invitations: study in women aged 56 years old in four French departments.
Poiseuil M; Moutel G; Cosson M; Quertier MC; Duchange N; Darquy S
Eur J Cancer Prev; 2023 May; 32(3):238-245. PubMed ID: 36779309
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey.
Duport N
Rev Epidemiol Sante Publique; 2012 Dec; 60(6):421-30. PubMed ID: 23146369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
